PMID- 36718059 OWN - NLM STAT- MEDLINE DCOM- 20230728 LR - 20230728 IS - 2772-2716 (Electronic) IS - 2772-2708 (Linking) VI - 17 IP - 1 DP - 2023 TI - Lymphocytic Esophagitis: A Case Series of Esophageal Disease with Increasing Frequency. PG - 79-84 LID - 10.2174/2772270817666230130093341 [doi] AB - BACKGROUND: Lymphocytic esophagitis (LE) is a poorly understood clinical finding that has been increasingly identified in the last decade. Previous studies proposed increased frequency of LE in elderly females, as well as associations with smoking and pediatric Crohn's disease. OBJECTIVE: We aimed to determine the patient characteristics and clinical features of our adult LE patients. As inflammation in the esophagus has been linked to cancer, this review also describes this association. However, there are no reported cases of malignant transformation in those with underlying lymphocytic esophagitis. METHODS: We retrospectively reviewed records for patients at the University of Missouri Hospital- Columbia (located in the USA) who had a histopathological diagnosis of LE. Cases of LE were identified using the pathology reporting system at the University of Missouri Hospital for esophageal biopsy specimens for the above-mentioned period. RESULTS: The data of a total of 20 adult cases with esophageal biopsy specimens consistent with LE were included. CONCLUSION: LE seems to be a benign but disturbing clinical problem and should be remembered in elderly females complaining of dysphagia or refractory reflux symptoms. It has similar endoscopic findings of eosinophilic esophagitis with rings and esophagitis. Smoking and hiatal hernia are common risk factors. The majority of LE patients can respond to proton pump inhibitor (PPI) therapy. Endoscopic dilations and steroid therapy should be considered for PPI nonresponder LE patients. CI - Copyright(c) Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. FAU - Yousef, Mohamad AU - Yousef M AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Chela, Harleen AU - Chela H AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Ertugrul, Hamza AU - Ertugrul H AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Albarrak, Abdulmajeed AU - Albarrak A AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Basar, Omer AU - Basar O AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Pasha, Syed AU - Pasha S AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Mousa, Yousef AU - Mousa Y AD - Department of Pediatrics, Right Way (Germany) Heidekreis-Klinikum GmbH Krankenhaus Walsrode, Walsrode, Germany. FAU - Al Juboori, Alhareth AU - Al Juboori A AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Frazier, Shellaine AU - Frazier S AD - Department of Pathology, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Tahan, Veysel AU - Tahan V AUID- ORCID: 0000-0001-6796-9359 AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. FAU - Daglilar, Ebubekir AU - Daglilar E AD - Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, Columbia, Missouri, Mo, USA. LA - eng PT - Journal Article PT - Review PL - Netherlands TA - Recent Adv Inflamm Allergy Drug Discov JT - Recent advances in inflammation & allergy drug discovery JID - 101776469 SB - IM MH - Adult MH - Female MH - Child MH - Humans MH - Aged MH - Retrospective Studies MH - *Eosinophilic Esophagitis/diagnosis MH - *Deglutition Disorders/epidemiology MH - Lymphocytes/pathology OTO - NOTNLM OT - Lymphocytic esophagitis OT - dysphagia OT - heartburn OT - inflammation OT - reflux disease OT - regurgitation EDAT- 2023/02/01 06:00 MHDA- 2023/07/28 06:43 CRDT- 2023/01/31 00:53 PHST- 2022/09/15 00:00 [received] PHST- 2022/12/19 00:00 [revised] PHST- 2022/12/30 00:00 [accepted] PHST- 2023/07/28 06:43 [medline] PHST- 2023/02/01 06:00 [pubmed] PHST- 2023/01/31 00:53 [entrez] AID - RAIAD-EPUB-129139 [pii] AID - 10.2174/2772270817666230130093341 [doi] PST - ppublish SO - Recent Adv Inflamm Allergy Drug Discov. 2023;17(1):79-84. doi: 10.2174/2772270817666230130093341.